Ropes & Gray is providing U.S. legal counsel to Mitsubishi Tanabe Pharma Corporation (MTPC) in its definitive arrangement agreement to acquire of all of the issued and outstanding common shares of Medicago Inc., other than the shares currently held by Philip Morris Investments B.V. an affiliate of Philip Morris International Inc. and MTPC, in a transaction valued at approximately $357 million. The transaction was announced on July 12, 2013; and upon its completion, Medicago will be jointly owned by MTPC (60%) and PMI (40%).
MTPC is a research-driven pharmaceutical company based in Japan and the acquisition of Medicago, a Canadian-based clinical-stage biopharmaceutical company with special strengths in research and development for new vaccines and therapeutic proteins, is expected to further MTPC’s efforts to advance their vaccine development in the global market.
MTPC is a research-driven pharmaceutical company based in Japan and the acquisition of Medicago, a Canadian-based clinical-stage biopharmaceutical company with special strengths in research and development for new vaccines and therapeutic proteins, is expected to further MTPC’s efforts to advance their vaccine development in the global market.
Stay Up To Date with Ropes & Gray
Subscribe to Our Podcast
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Follow Us on Social
Stay in the loop with all things Ropes & Gray, and find our more about our people, culture, initiatives and everything that’s happening.
Join Our Mailing List
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.